Cargando…

Derepressing muscleblind expression by miRNA sponges ameliorates myotonic dystrophy-like phenotypes in Drosophila

Myotonic Dystrophy type 1 (DM1) originates from alleles of the DMPK gene with hundreds of extra CTG repeats in the 3′ untranslated region (3′ UTR). CUG repeat RNAs accumulate in foci that sequester Muscleblind-like (MBNL) proteins away from their functional target transcripts. Endogenous upregulatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerro-Herreros, Estefania, Fernandez-Costa, Juan M., Sabater-Arcis, María, Llamusi, Beatriz, Artero, Ruben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090246/ https://www.ncbi.nlm.nih.gov/pubmed/27805016 http://dx.doi.org/10.1038/srep36230

Ejemplares similares

miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models
por: Cerro-Herreros, Estefania, et al.
Publicado: (2018)

Two Enhancers Control Transcription of Drosophila muscleblind in the Embryonic Somatic Musculature and in the Central Nervous System
por: Bargiela, Ariadna, et al.
Publicado: (2014)

Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model
por: Llamusi, Beatriz, et al.
Publicado: (2013)

Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes
por: Cerro-Herreros, Estefania, et al.
Publicado: (2017)

Increased autophagy and apoptosis contribute to muscle atrophy in a myotonic dystrophy type 1 Drosophila model
por: Bargiela, Ariadna, et al.
Publicado: (2015)

Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila
por: Chakraborty, Mouli, et al.
Publicado: (2018)

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2020)

Compound loss of muscleblind-like function in myotonic dystrophy
por: Lee, Kuang-Yung, et al.
Publicado: (2013)

miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
por: Sabater-Arcis, Maria, et al.
Publicado: (2019)

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction
por: Chakraborty, Mouli, et al.
Publicado: (2015)

Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
por: Overby, Sarah J., et al.
Publicado: (2022)

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers
por: Fernandez-Costa, Juan M., et al.
Publicado: (2016)

Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy
por: Machuca-Tzili, Laura E., et al.
Publicado: (2011)

Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
por: Chakraborty, Mouli, et al.
Publicado: (2018)

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2021)

Defined d-hexapeptides bind CUG repeats and rescue phenotypes of myotonic dystrophy myotubes in a Drosophila model of the disease
por: Rapisarda, Anna, et al.
Publicado: (2021)

BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA(LR) Mice
por: Overby, Sarah J., et al.
Publicado: (2023)

Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
por: González-Martínez, Irene, et al.
Publicado: (2023)

Musashi-2 contributes to myotonic dystrophy muscle dysfunction by promoting excessive autophagy through miR-7 biogenesis repression
por: Sabater-Arcis, Maria, et al.
Publicado: (2021)

Drosophila Muscleblind Is Involved in troponin T Alternative Splicing and Apoptosis
por: Vicente-Crespo, Marta, et al.
Publicado: (2008)

Muscleblind-Like 1 Knockout Mice Reveal Novel Splicing Defects in the Myotonic Dystrophy Brain
por: Suenaga, Koichi, et al.
Publicado: (2012)

Muscleblind-like1 Undergoes Ectopic Relocation in the Nuclei of Skeletal Muscles in Myotonic Dystrophy and Sarcopenia
por: Malatesta, M., et al.
Publicado: (2013)

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences
por: Sellier, Chantal, et al.
Publicado: (2018)

In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models
por: González, Àlex L., et al.
Publicado: (2017)

Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy
por: Choi, Jongkyu, et al.
Publicado: (2016)

Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy
por: Chen, Gang, et al.
Publicado: (2018)

MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
por: López Castel, Arturo, et al.
Publicado: (2019)

Optical Mapping Approaches on Muscleblind‐Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy
por: Chou, Chung‐Chuan, et al.
Publicado: (2017)

Muscleblind1, but Not Dmpk or Six5, Contributes to a Complex Phenotype of Muscular and Motivational Deficits in Mouse Models of Myotonic Dystrophy
por: Matynia, Anna, et al.
Publicado: (2010)

Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy
por: Edokpolor, Kamyra S., et al.
Publicado: (2022)

Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021)

Development of a Drosophila melanogaster spliceosensor system for in vivo high-throughput screening in myotonic dystrophy type 1
por: García-Alcover, Irma, et al.
Publicado: (2014)

Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
por: Espinosa-Espinosa, Jorge, et al.
Publicado: (2022)

Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice
por: Bargiela, Ariadna, et al.
Publicado: (2023)

Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene
por: Llamusí, Beatriz, et al.
Publicado: (2008)

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
por: Koehorst, Emma, et al.
Publicado: (2020)

Modeling Myotonic Dystrophy Type 2 Using Drosophila melanogaster
por: Marzullo, Marta, et al.
Publicado: (2023)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g7jmo4a6rik1853e91qq1hocgm